Wei et al., using microarray analysis of tissue samples, observed a 13% and 14% IDO1 expression rate in thymomas and TCs, respectively, and a survival benefit in patients with low IDO1 and high FOXP3 Tregs expression levels [75]. The gene discussed is IDO1; the disease is thymoma.